

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.07263445 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.42656735 |
| 3 | regulation of gamma-delta T cell activation (GO:0046643) | 5.00360457 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97963724 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.97963724 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60915901 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.57712850 |
| 8 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.52224933 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.47523055 |
| 10 | negative T cell selection (GO:0043383) | 4.45456338 |
| 11 | regulation of histone H3-K27 methylation (GO:0061085) | 4.45242622 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.18790030 |
| 13 | positive T cell selection (GO:0043368) | 4.17269388 |
| 14 | T cell selection (GO:0045058) | 3.97713950 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.95743942 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.93192445 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90673312 |
| 18 | thymic T cell selection (GO:0045061) | 3.86076967 |
| 19 | histone H3-K36 demethylation (GO:0070544) | 3.77168804 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68866760 |
| 21 | regulation of B cell differentiation (GO:0045577) | 3.64021757 |
| 22 | interferon-gamma production (GO:0032609) | 3.63785848 |
| 23 | interkinetic nuclear migration (GO:0022027) | 3.62363403 |
| 24 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.61360541 |
| 25 | cellular response to ethanol (GO:0071361) | 3.53134347 |
| 26 | response to interleukin-15 (GO:0070672) | 3.47837829 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.46406814 |
| 28 | definitive hemopoiesis (GO:0060216) | 3.45706351 |
| 29 | nuclear pore complex assembly (GO:0051292) | 3.43617544 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38869080 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.38869080 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36981506 |
| 33 | histone H3-K4 trimethylation (GO:0080182) | 3.35679142 |
| 34 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.35120747 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 3.34831841 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.34549642 |
| 37 | hepatocyte apoptotic process (GO:0097284) | 3.17481699 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.13824728 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 3.11616304 |
| 40 | T cell homeostasis (GO:0043029) | 3.06679641 |
| 41 | tolerance induction (GO:0002507) | 3.06271991 |
| 42 | iron ion import (GO:0097286) | 2.97840645 |
| 43 | positive regulation of interleukin-2 production (GO:0032743) | 2.96096831 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94052094 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94006878 |
| 46 | nuclear pore organization (GO:0006999) | 2.93701913 |
| 47 | T cell costimulation (GO:0031295) | 2.92011007 |
| 48 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.90438692 |
| 49 | lymphocyte homeostasis (GO:0002260) | 2.89238715 |
| 50 | growth hormone receptor signaling pathway (GO:0060396) | 2.87841931 |
| 51 | megakaryocyte development (GO:0035855) | 2.87389966 |
| 52 | T cell receptor signaling pathway (GO:0050852) | 2.86682138 |
| 53 | leukocyte aggregation (GO:0070486) | 2.85803314 |
| 54 | lymphocyte costimulation (GO:0031294) | 2.85596540 |
| 55 | regulation of establishment of cell polarity (GO:2000114) | 2.85474066 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84672513 |
| 57 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84398187 |
| 58 | peptidyl-lysine trimethylation (GO:0018023) | 2.82126792 |
| 59 | B cell homeostasis (GO:0001782) | 2.82059588 |
| 60 | embryonic hemopoiesis (GO:0035162) | 2.82000059 |
| 61 | V(D)J recombination (GO:0033151) | 2.80407293 |
| 62 | cellular response to interleukin-15 (GO:0071350) | 2.79319872 |
| 63 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.78735112 |
| 64 | regulation of RNA export from nucleus (GO:0046831) | 2.78408265 |
| 65 | T cell migration (GO:0072678) | 2.78358345 |
| 66 | histone lysine demethylation (GO:0070076) | 2.78113135 |
| 67 | lymph node development (GO:0048535) | 2.78055304 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 2.73402063 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72100606 |
| 70 | regulation of necroptotic process (GO:0060544) | 2.71342908 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69970275 |
| 72 | mitotic sister chromatid cohesion (GO:0007064) | 2.66131745 |
| 73 | T cell differentiation (GO:0030217) | 2.65886050 |
| 74 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.63721825 |
| 75 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.63263263 |
| 76 | cellular response to zinc ion (GO:0071294) | 2.62774181 |
| 77 | alpha-beta T cell activation (GO:0046631) | 2.62761888 |
| 78 | histone demethylation (GO:0016577) | 2.61857672 |
| 79 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.61757873 |
| 80 | B cell proliferation (GO:0042100) | 2.60061632 |
| 81 | histone H3-K4 methylation (GO:0051568) | 2.58839721 |
| 82 | T-helper cell differentiation (GO:0042093) | 2.58738810 |
| 83 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.58738810 |
| 84 | regulation of response to interferon-gamma (GO:0060330) | 2.58530855 |
| 85 | histone H3-K9 demethylation (GO:0033169) | 2.57287558 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56700153 |
| 87 | positive regulation of mRNA catabolic process (GO:0061014) | 2.55774351 |
| 88 | hypotonic response (GO:0006971) | 2.55754310 |
| 89 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.55676701 |
| 90 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.55676701 |
| 91 | protein K48-linked deubiquitination (GO:0071108) | 2.54498847 |
| 92 | leukocyte homeostasis (GO:0001776) | 2.54194295 |
| 93 | peptidyl-lysine methylation (GO:0018022) | 2.54192809 |
| 94 | regulation of B cell proliferation (GO:0030888) | 2.53999337 |
| 95 | positive regulation of interferon-alpha production (GO:0032727) | 2.53460599 |
| 96 | alpha-beta T cell differentiation (GO:0046632) | 2.53255252 |
| 97 | positive regulation of humoral immune response (GO:0002922) | 2.53173791 |
| 98 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.52701493 |
| 99 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52588232 |
| 100 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.52482377 |
| 101 | negative regulation of phagocytosis (GO:0050765) | 2.52245220 |
| 102 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.52151933 |
| 103 | mature B cell differentiation (GO:0002335) | 2.51602654 |
| 104 | regulation of regulatory T cell differentiation (GO:0045589) | 2.51211222 |
| 105 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.49600507 |
| 106 | Peyers patch development (GO:0048541) | 2.49600507 |
| 107 | natural killer cell differentiation (GO:0001779) | 2.49582501 |
| 108 | negative regulation of DNA repair (GO:0045738) | 2.49521250 |
| 109 | lipid translocation (GO:0034204) | 2.47704234 |
| 110 | phospholipid translocation (GO:0045332) | 2.47704234 |
| 111 | negative regulation of B cell proliferation (GO:0030889) | 2.45982392 |
| 112 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.45433410 |
| 113 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.45433410 |
| 114 | regulation of protein polyubiquitination (GO:1902914) | 2.45221635 |
| 115 | positive regulation of isotype switching (GO:0045830) | 2.44397637 |
| 116 | positive regulation of protein deacetylation (GO:0090312) | 2.44118184 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.43969109 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43608326 |
| 119 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43595072 |
| 120 | establishment of protein localization to Golgi (GO:0072600) | 2.43140974 |
| 121 | cellular response to growth hormone stimulus (GO:0071378) | 2.42488438 |
| 122 | positive regulation by host of viral transcription (GO:0043923) | 2.42355521 |
| 123 | regulation of tolerance induction (GO:0002643) | 2.41584187 |
| 124 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.41060774 |
| 125 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.41006537 |
| 126 | cellular extravasation (GO:0045123) | 2.39654473 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.39351518 |
| 128 | positive regulation of B cell activation (GO:0050871) | 2.38942343 |
| 129 | negative regulation of stress fiber assembly (GO:0051497) | 2.38509690 |
| 130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37774932 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37774932 |
| 132 | regulation of mRNA catabolic process (GO:0061013) | 2.36767645 |
| 133 | germinal center formation (GO:0002467) | 2.36616963 |
| 134 | response to type I interferon (GO:0034340) | 2.35814099 |
| 135 | coronary vasculature morphogenesis (GO:0060977) | 2.35507960 |
| 136 | natural killer cell activation (GO:0030101) | 2.34981612 |
| 137 | regulation of granulocyte differentiation (GO:0030852) | 2.34738509 |
| 138 | pericardium development (GO:0060039) | 2.32892010 |
| 139 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.32745514 |
| 140 | histone mRNA catabolic process (GO:0071044) | 2.32635428 |
| 141 | T cell lineage commitment (GO:0002360) | 2.32304516 |
| 142 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.31609691 |
| 143 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.31056986 |
| 144 | striated muscle atrophy (GO:0014891) | 2.29481782 |
| 145 | regulation of interferon-alpha production (GO:0032647) | 2.29083551 |
| 146 | angiogenesis involved in wound healing (GO:0060055) | 2.28853087 |
| 147 | type I interferon signaling pathway (GO:0060337) | 2.26490421 |
| 148 | cellular response to type I interferon (GO:0071357) | 2.26490421 |
| 149 | modulation by symbiont of host immune response (GO:0052553) | 2.25782400 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.25782400 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.25782400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.03848770 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.94025352 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16399315 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.18538008 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15434105 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.98524402 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.91034509 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90847371 |
| 9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.90215218 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88802928 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82952707 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80587100 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62478126 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58601201 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.37442329 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32843638 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32669842 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27229763 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22974416 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.20248113 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15373412 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11769104 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08066781 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07624938 |
| 25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.07158517 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07089805 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.06003956 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.98063152 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96368946 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94187480 |
| 31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93187413 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.93029418 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88956570 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86850929 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83597767 |
| 36 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83543043 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81455710 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79154032 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76650162 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72012617 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71493147 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70825247 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70357158 |
| 44 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69555234 |
| 45 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66776612 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.65712440 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51752064 |
| 48 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50628459 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50194584 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50032232 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44406591 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44033680 |
| 53 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42457372 |
| 54 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.40141359 |
| 55 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39323163 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36937219 |
| 57 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36082602 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33512323 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33231211 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33178937 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30929968 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30020535 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27791685 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27601117 |
| 65 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26797727 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26494762 |
| 67 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.25918222 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25296288 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25201512 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24765346 |
| 71 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23737418 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19821456 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19670009 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19006973 |
| 75 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16836251 |
| 76 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16772850 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16655469 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16365833 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15990661 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15240917 |
| 81 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15010163 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12163457 |
| 83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11763313 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10276854 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10258559 |
| 86 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09764006 |
| 87 | * MAF_26560356_Chip-Seq_TH2_Human | 1.09287099 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08434795 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07801570 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07693341 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07677518 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07553821 |
| 93 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06942587 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06262966 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05985121 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05723784 |
| 97 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03811649 |
| 98 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01901729 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00919177 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00785643 |
| 101 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00615347 |
| 102 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00615347 |
| 103 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99877886 |
| 104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98763754 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98450570 |
| 106 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98376444 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96715308 |
| 108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96428519 |
| 109 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95662398 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95655970 |
| 111 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95611450 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93846229 |
| 113 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92962971 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91910114 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89993817 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88824030 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88672544 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88166479 |
| 119 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87727007 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87704784 |
| 121 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87700778 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87335377 |
| 123 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86609382 |
| 124 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86217801 |
| 125 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85200443 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83885026 |
| 127 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82354273 |
| 128 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82354273 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82060625 |
| 130 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81890839 |
| 131 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.81535160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.98996867 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.03870091 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.01319815 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.65074301 |
| 5 | MP0001800_abnormal_humoral_immune | 2.62287160 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.61698160 |
| 7 | MP0000685_abnormal_immune_system | 2.57268246 |
| 8 | MP0005387_immune_system_phenotype | 2.47018045 |
| 9 | MP0001790_abnormal_immune_system | 2.47018045 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.40291015 |
| 11 | MP0002006_tumorigenesis | 2.37434927 |
| 12 | MP0005671_abnormal_response_to | 2.28669561 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.25627541 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.22637798 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.06331496 |
| 16 | * MP0002398_abnormal_bone_marrow | 1.98002374 |
| 17 | MP0005360_urolithiasis | 1.96432183 |
| 18 | MP0003436_decreased_susceptibility_to | 1.95094946 |
| 19 | MP0002723_abnormal_immune_serum | 1.94783241 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.92602126 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.89977562 |
| 22 | MP0004947_skin_inflammation | 1.88924062 |
| 23 | MP0001873_stomach_inflammation | 1.86753137 |
| 24 | MP0001819_abnormal_immune_cell | 1.86585042 |
| 25 | MP0003303_peritoneal_inflammation | 1.80938665 |
| 26 | MP0009278_abnormal_bone_marrow | 1.80845058 |
| 27 | MP0003724_increased_susceptibility_to | 1.80377315 |
| 28 | MP0001853_heart_inflammation | 1.73269449 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.73186901 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.73186901 |
| 31 | * MP0000716_abnormal_immune_system | 1.71827354 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.71290672 |
| 33 | MP0002405_respiratory_system_inflammati | 1.69462777 |
| 34 | MP0005310_abnormal_salivary_gland | 1.68539469 |
| 35 | MP0009785_altered_susceptibility_to | 1.66685905 |
| 36 | * MP0000689_abnormal_spleen_morphology | 1.66060575 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.64394469 |
| 38 | MP0002009_preneoplasia | 1.63409320 |
| 39 | MP0002722_abnormal_immune_system | 1.63360957 |
| 40 | MP0005451_abnormal_body_composition | 1.62398341 |
| 41 | * MP0000703_abnormal_thymus_morphology | 1.62011897 |
| 42 | MP0005025_abnormal_response_to | 1.60816604 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.54180999 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.53611486 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.51538321 |
| 46 | MP0002419_abnormal_innate_immunity | 1.43867798 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.42592340 |
| 48 | * MP0002429_abnormal_blood_cell | 1.42187503 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.41220293 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.39665394 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.37511577 |
| 52 | MP0002933_joint_inflammation | 1.35079715 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.33825281 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.30991289 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.30091223 |
| 56 | MP0005365_abnormal_bile_salt | 1.28615587 |
| 57 | MP0004510_myositis | 1.28008351 |
| 58 | MP0003828_pulmonary_edema | 1.25861828 |
| 59 | MP0003252_abnormal_bile_duct | 1.25336997 |
| 60 | MP0009115_abnormal_fat_cell | 1.24747420 |
| 61 | MP0006054_spinal_hemorrhage | 1.24393990 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.23087874 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.21703640 |
| 64 | MP0000383_abnormal_hair_follicle | 1.19858193 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.14792438 |
| 66 | MP0001851_eye_inflammation | 1.13454359 |
| 67 | MP0004381_abnormal_hair_follicle | 1.13443848 |
| 68 | MP0003045_fibrosis | 1.12361946 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.11536128 |
| 70 | MP0003866_abnormal_defecation | 1.11232516 |
| 71 | MP0000371_diluted_coat_color | 1.10062937 |
| 72 | MP0002060_abnormal_skin_morphology | 1.08464050 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.07059270 |
| 74 | MP0005023_abnormal_wound_healing | 1.06743116 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.06276604 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.06051200 |
| 77 | MP0000609_abnormal_liver_physiology | 1.05185417 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.04831195 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.04470284 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.04204259 |
| 81 | MP0003943_abnormal_hepatobiliary_system | 1.01942332 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.99511993 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.98397288 |
| 84 | MP0004883_abnormal_blood_vessel | 0.96300664 |
| 85 | MP0002796_impaired_skin_barrier | 0.95781343 |
| 86 | MP0003091_abnormal_cell_migration | 0.95101111 |
| 87 | MP0000733_abnormal_muscle_development | 0.94279104 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92623628 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.92271773 |
| 90 | MP0003868_abnormal_feces_composition | 0.89921581 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.89540682 |
| 92 | MP0003279_aneurysm | 0.89417233 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.88373276 |
| 94 | MP0008469_abnormal_protein_level | 0.87549898 |
| 95 | MP0006082_CNS_inflammation | 0.85652222 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 0.85430788 |
| 97 | MP0001243_abnormal_dermal_layer | 0.84614454 |
| 98 | MP0010307_abnormal_tumor_latency | 0.84512674 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.84155870 |
| 100 | MP0005164_abnormal_response_to | 0.83932037 |
| 101 | MP0002254_reproductive_system_inflammat | 0.83657547 |
| 102 | MP0005621_abnormal_cell_physiology | 0.83610235 |
| 103 | MP0009764_decreased_sensitivity_to | 0.83098551 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.82708480 |
| 105 | MP0004130_abnormal_muscle_cell | 0.81551654 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.81385405 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.81284339 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.79730276 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.79016854 |
| 110 | MP0005174_abnormal_tail_pigmentation | 0.78635841 |
| 111 | MP0003448_altered_tumor_morphology | 0.78266662 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.78157066 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.77579356 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.75897005 |
| 115 | MP0005275_abnormal_skin_tensile | 0.75381686 |
| 116 | MP0002088_abnormal_embryonic_growth/wei | 0.75020329 |
| 117 | MP0009931_abnormal_skin_appearance | 0.75000018 |
| 118 | MP0009763_increased_sensitivity_to | 0.74972015 |
| 119 | MP0000249_abnormal_blood_vessel | 0.74808489 |
| 120 | MP0002168_other_aberrant_phenotype | 0.74695954 |
| 121 | MP0002971_abnormal_brown_adipose | 0.74007437 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.73877988 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73582019 |
| 124 | MP0003984_embryonic_growth_retardation | 0.73019330 |
| 125 | MP0005670_abnormal_white_adipose | 0.72980130 |
| 126 | MP0001191_abnormal_skin_condition | 0.72221482 |
| 127 | MP0002925_abnormal_cardiovascular_devel | 0.71977891 |
| 128 | MP0005409_darkened_coat_color | 0.71969323 |
| 129 | MP0010630_abnormal_cardiac_muscle | 0.70944997 |
| 130 | MP0001784_abnormal_fluid_regulation | 0.70062688 |
| 131 | MP0000598_abnormal_liver_morphology | 0.69630641 |
| 132 | MP0001915_intracranial_hemorrhage | 0.69499294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.69184040 |
| 2 | T lymphocytopenia (HP:0005403) | 4.57810897 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.40036748 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.26712919 |
| 5 | Thyroiditis (HP:0100646) | 4.22741743 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.16115603 |
| 7 | B lymphocytopenia (HP:0010976) | 4.16115603 |
| 8 | Recurrent viral infections (HP:0004429) | 4.13537262 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 4.00911814 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.77762015 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.47853014 |
| 12 | Combined immunodeficiency (HP:0005387) | 3.37192685 |
| 13 | Hypoplasia of the thymus (HP:0000778) | 3.27471599 |
| 14 | Cellulitis (HP:0100658) | 3.20690575 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.17335297 |
| 16 | Abnormality of T cells (HP:0002843) | 3.13979088 |
| 17 | Papilloma (HP:0012740) | 3.10864824 |
| 18 | Verrucae (HP:0200043) | 3.10864824 |
| 19 | Eosinophilia (HP:0001880) | 3.07617321 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.04550059 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.04375726 |
| 22 | IgM deficiency (HP:0002850) | 2.97024419 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95725903 |
| 24 | Subacute progressive viral hepatitis (HP:0006572) | 2.91522555 |
| 25 | Colitis (HP:0002583) | 2.89450700 |
| 26 | Chronic otitis media (HP:0000389) | 2.82072613 |
| 27 | Meningitis (HP:0001287) | 2.79963637 |
| 28 | Myocardial infarction (HP:0001658) | 2.73723504 |
| 29 | Abnormality of eosinophils (HP:0001879) | 2.64546851 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.62677642 |
| 31 | Granulocytopenia (HP:0001913) | 2.61103292 |
| 32 | Mitral stenosis (HP:0001718) | 2.60743170 |
| 33 | Neonatal hypoglycemia (HP:0001998) | 2.57516259 |
| 34 | Aortic aneurysm (HP:0004942) | 2.54050478 |
| 35 | Genetic anticipation (HP:0003743) | 2.53656225 |
| 36 | Papilledema (HP:0001085) | 2.53387338 |
| 37 | IgG deficiency (HP:0004315) | 2.53346198 |
| 38 | Chronic diarrhea (HP:0002028) | 2.51961213 |
| 39 | Hematochezia (HP:0002573) | 2.50015028 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.48491268 |
| 41 | Gastrointestinal stroma tumor (HP:0100723) | 2.47718947 |
| 42 | Viral hepatitis (HP:0006562) | 2.44054429 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43048175 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43048175 |
| 45 | Acute myeloid leukemia (HP:0004808) | 2.43020778 |
| 46 | Dysmetric saccades (HP:0000641) | 2.42471022 |
| 47 | Arterial thrombosis (HP:0004420) | 2.42147736 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.40487881 |
| 49 | Myositis (HP:0100614) | 2.40370854 |
| 50 | Macroorchidism (HP:0000053) | 2.39088680 |
| 51 | Long eyelashes (HP:0000527) | 2.37854119 |
| 52 | Gingival bleeding (HP:0000225) | 2.36603425 |
| 53 | Papillary thyroid carcinoma (HP:0002895) | 2.35179112 |
| 54 | Lymphopenia (HP:0001888) | 2.35047273 |
| 55 | Eczematoid dermatitis (HP:0000976) | 2.33884474 |
| 56 | Overgrowth (HP:0001548) | 2.33609698 |
| 57 | Leukocytosis (HP:0001974) | 2.32183965 |
| 58 | Thrombocytosis (HP:0001894) | 2.31506985 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.29981024 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28723895 |
| 61 | Vasculitis (HP:0002633) | 2.28559049 |
| 62 | IgA deficiency (HP:0002720) | 2.26813825 |
| 63 | Osteomyelitis (HP:0002754) | 2.23951355 |
| 64 | Ankyloglossia (HP:0010296) | 2.23363458 |
| 65 | Pustule (HP:0200039) | 2.22083878 |
| 66 | Coarse hair (HP:0002208) | 2.21957941 |
| 67 | Impaired platelet aggregation (HP:0003540) | 2.20717143 |
| 68 | Abnormal platelet function (HP:0011869) | 2.20717143 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20211046 |
| 70 | Generalized hypopigmentation of hair (HP:0011358) | 2.19995275 |
| 71 | Curly hair (HP:0002212) | 2.17824777 |
| 72 | Periodontitis (HP:0000704) | 2.17776814 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.16886715 |
| 74 | Fair hair (HP:0002286) | 2.16748444 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15688263 |
| 76 | Epistaxis (HP:0000421) | 2.12728532 |
| 77 | Sandal gap (HP:0001852) | 2.11555407 |
| 78 | Increased mean platelet volume (HP:0011877) | 2.09244736 |
| 79 | Abnormality of secondary sexual hair (HP:0009888) | 2.07090657 |
| 80 | Abnormality of the axillary hair (HP:0100134) | 2.07090657 |
| 81 | Broad face (HP:0000283) | 2.05907416 |
| 82 | Asymmetry of the thorax (HP:0001555) | 2.05168389 |
| 83 | Sepsis (HP:0100806) | 2.05067673 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04759855 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.04759855 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.04514326 |
| 87 | Germ cell neoplasia (HP:0100728) | 2.03898379 |
| 88 | Flat acetabular roof (HP:0003180) | 2.03677607 |
| 89 | Syringomyelia (HP:0003396) | 2.03639390 |
| 90 | Spinal cord lesions (HP:0100561) | 2.03639390 |
| 91 | Depressed nasal tip (HP:0000437) | 2.03210498 |
| 92 | Abnormality of oral frenula (HP:0000190) | 2.02926897 |
| 93 | Pulmonary embolism (HP:0002204) | 2.02840677 |
| 94 | Hyperkalemia (HP:0002153) | 2.02495877 |
| 95 | Truncal obesity (HP:0001956) | 2.01055186 |
| 96 | Sparse lateral eyebrow (HP:0005338) | 2.00315957 |
| 97 | Dislocated radial head (HP:0003083) | 2.00136603 |
| 98 | Deep venous thrombosis (HP:0002625) | 1.99782433 |
| 99 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.99780428 |
| 100 | Abnormality of the nasal septum (HP:0000419) | 1.98642601 |
| 101 | Subaortic stenosis (HP:0001682) | 1.97233929 |
| 102 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.97233929 |
| 103 | Recurrent sinusitis (HP:0011108) | 1.97035920 |
| 104 | Pulmonary infiltrates (HP:0002113) | 1.96247239 |
| 105 | Prominent nose (HP:0000448) | 1.93795031 |
| 106 | Spondylolisthesis (HP:0003302) | 1.93740409 |
| 107 | Lip pit (HP:0100267) | 1.93687272 |
| 108 | Calf muscle hypertrophy (HP:0008981) | 1.93663050 |
| 109 | Orchitis (HP:0100796) | 1.91369044 |
| 110 | Recurrent skin infections (HP:0001581) | 1.91332725 |
| 111 | Persistence of primary teeth (HP:0006335) | 1.91270923 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 1.91207683 |
| 113 | Emphysema (HP:0002097) | 1.91066209 |
| 114 | Abnormality of the intervertebral disk (HP:0005108) | 1.90513285 |
| 115 | Gingivitis (HP:0000230) | 1.88888332 |
| 116 | Heterotopia (HP:0002282) | 1.88526204 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 1.86925606 |
| 118 | Recurrent bacterial skin infections (HP:0005406) | 1.84737352 |
| 119 | Retrobulbar optic neuritis (HP:0100654) | 1.84725834 |
| 120 | Optic neuritis (HP:0100653) | 1.84725834 |
| 121 | Cutis marmorata (HP:0000965) | 1.83353261 |
| 122 | Hypoproteinemia (HP:0003075) | 1.82313138 |
| 123 | Thick nail (HP:0001805) | 1.81735611 |
| 124 | Encephalitis (HP:0002383) | 1.81611393 |
| 125 | Increased IgE level (HP:0003212) | 1.80975018 |
| 126 | Nasal polyposis (HP:0100582) | 1.80741437 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 1.80725940 |
| 128 | Fatigue (HP:0012378) | 1.80381935 |
| 129 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80355520 |
| 130 | Volvulus (HP:0002580) | 1.79817606 |
| 131 | Polycythemia (HP:0001901) | 1.78986541 |
| 132 | Mediastinal lymphadenopathy (HP:0100721) | 1.77882430 |
| 133 | Glucose intolerance (HP:0000833) | 1.77848767 |
| 134 | Keratoconjunctivitis sicca (HP:0001097) | 1.76888328 |
| 135 | Arterial tortuosity (HP:0005116) | 1.76439638 |
| 136 | Hepatitis (HP:0012115) | 1.76151013 |
| 137 | Abnormality of the radial head (HP:0003995) | 1.75877691 |
| 138 | Bicuspid aortic valve (HP:0001647) | 1.75688429 |
| 139 | Bladder carcinoma (HP:0002862) | 1.75602583 |
| 140 | Bladder neoplasm (HP:0009725) | 1.75602583 |
| 141 | Abnormal glucose tolerance (HP:0001952) | 1.74831338 |
| 142 | Mitral valve prolapse (HP:0001634) | 1.74260014 |
| 143 | Conjunctival telangiectasia (HP:0000524) | 1.73394851 |
| 144 | Deep philtrum (HP:0002002) | 1.73375563 |
| 145 | Limited elbow extension (HP:0001377) | 1.72821259 |
| 146 | Narrow palate (HP:0000189) | 1.72686487 |
| 147 | Stomatitis (HP:0010280) | 1.70988816 |
| 148 | Skin ulcer (HP:0200042) | 1.70709372 |
| 149 | Ectropion (HP:0000656) | 1.70633156 |
| 150 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.70511313 |
| 151 | Aortic dissection (HP:0002647) | 1.70483227 |
| 152 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.68635316 |
| 153 | Advanced eruption of teeth (HP:0006288) | 1.67914662 |
| 154 | Recurrent abscess formation (HP:0002722) | 1.67090129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.17861534 |
| 2 | TXK | 2.99120745 |
| 3 | AKT3 | 2.89609082 |
| 4 | MAP3K10 | 2.64614544 |
| 5 | CDK12 | 2.36638330 |
| 6 | MAP3K14 | 2.28284174 |
| 7 | FGFR3 | 2.24860406 |
| 8 | PRPF4B | 2.20959065 |
| 9 | STK10 | 2.18123330 |
| 10 | JAK3 | 2.14498186 |
| 11 | FGFR4 | 2.07788323 |
| 12 | TYK2 | 1.94480841 |
| 13 | INSRR | 1.92387823 |
| 14 | EEF2K | 1.88663283 |
| 15 | JAK1 | 1.80621189 |
| 16 | TGFBR2 | 1.73407581 |
| 17 | ERN1 | 1.72207385 |
| 18 | ITK | 1.71717617 |
| 19 | SIK1 | 1.62673672 |
| 20 | IKBKE | 1.61785213 |
| 21 | NLK | 1.61019230 |
| 22 | CAMK1D | 1.58014402 |
| 23 | LATS1 | 1.56777284 |
| 24 | MAP3K2 | 1.55603831 |
| 25 | RIPK4 | 1.53764374 |
| 26 | EPHB1 | 1.51418469 |
| 27 | ZAP70 | 1.49737016 |
| 28 | GRK6 | 1.47128004 |
| 29 | WNK1 | 1.41644376 |
| 30 | FRK | 1.41604853 |
| 31 | MAP3K13 | 1.39921053 |
| 32 | FGFR2 | 1.38531029 |
| 33 | CHUK | 1.37701004 |
| 34 | TEC | 1.35351600 |
| 35 | PIM1 | 1.33779975 |
| 36 | MAP3K7 | 1.33148104 |
| 37 | BTK | 1.28268483 |
| 38 | NUAK1 | 1.27358670 |
| 39 | IKBKB | 1.24119211 |
| 40 | CDK9 | 1.23410757 |
| 41 | CSK | 1.22169340 |
| 42 | STK3 | 1.21974242 |
| 43 | SYK | 1.21260522 |
| 44 | DMPK | 1.20961869 |
| 45 | CSF1R | 1.20837926 |
| 46 | STK4 | 1.18566884 |
| 47 | PIK3CG | 1.15120414 |
| 48 | HCK | 1.13243166 |
| 49 | TAOK3 | 1.12507504 |
| 50 | CAMK1G | 1.11478500 |
| 51 | TBK1 | 1.10289138 |
| 52 | EPHA3 | 1.09367326 |
| 53 | CAMKK2 | 1.08221368 |
| 54 | NEK9 | 1.08070117 |
| 55 | LRRK2 | 1.07827674 |
| 56 | LCK | 1.04945868 |
| 57 | KIT | 1.04161358 |
| 58 | PDGFRB | 1.03460057 |
| 59 | RPS6KA4 | 1.02500352 |
| 60 | STK24 | 1.01864309 |
| 61 | YES1 | 1.01341995 |
| 62 | TIE1 | 1.01069318 |
| 63 | CDK6 | 1.00483193 |
| 64 | SMG1 | 0.98640576 |
| 65 | PRKCQ | 0.96755536 |
| 66 | TRPM7 | 0.96471510 |
| 67 | BMPR2 | 0.95356060 |
| 68 | MARK3 | 0.94538742 |
| 69 | TTN | 0.94177423 |
| 70 | SGK3 | 0.93727241 |
| 71 | MAP2K3 | 0.93366090 |
| 72 | BRD4 | 0.93240967 |
| 73 | JAK2 | 0.91187237 |
| 74 | PKN2 | 0.90294057 |
| 75 | MAPK7 | 0.89160449 |
| 76 | CDK4 | 0.86602017 |
| 77 | PDGFRA | 0.85911500 |
| 78 | ICK | 0.85381963 |
| 79 | CDC42BPA | 0.84791212 |
| 80 | ZAK | 0.82525806 |
| 81 | PTK6 | 0.81724710 |
| 82 | NEK6 | 0.81437185 |
| 83 | MAP3K3 | 0.78176961 |
| 84 | TRIB3 | 0.77927918 |
| 85 | STK38 | 0.75382542 |
| 86 | MELK | 0.74626109 |
| 87 | TAF1 | 0.74567856 |
| 88 | SGK2 | 0.74172545 |
| 89 | MST4 | 0.73741589 |
| 90 | SGK223 | 0.73566108 |
| 91 | SGK494 | 0.73566108 |
| 92 | PDK1 | 0.71435595 |
| 93 | MAPK12 | 0.69325375 |
| 94 | TGFBR1 | 0.69238992 |
| 95 | SCYL2 | 0.67874551 |
| 96 | HIPK2 | 0.67671255 |
| 97 | PRKAA2 | 0.66107367 |
| 98 | PRKCH | 0.63931789 |
| 99 | FES | 0.62922343 |
| 100 | MAPK11 | 0.62251352 |
| 101 | RPS6KB2 | 0.61774087 |
| 102 | IRAK3 | 0.60681623 |
| 103 | SIK3 | 0.60360896 |
| 104 | IRAK1 | 0.59188953 |
| 105 | LYN | 0.58467607 |
| 106 | EIF2AK3 | 0.57552553 |
| 107 | RET | 0.57491750 |
| 108 | IRAK4 | 0.55570954 |
| 109 | SIK2 | 0.54471675 |
| 110 | MTOR | 0.52493154 |
| 111 | PRKD2 | 0.51564715 |
| 112 | RPS6KA5 | 0.51243126 |
| 113 | PIK3CA | 0.50917715 |
| 114 | CLK1 | 0.50863432 |
| 115 | MARK2 | 0.49728700 |
| 116 | TNK2 | 0.49588707 |
| 117 | MAP3K1 | 0.49548128 |
| 118 | RPS6KB1 | 0.48859863 |
| 119 | MAPK4 | 0.48792872 |
| 120 | RIPK1 | 0.48347614 |
| 121 | BLK | 0.48122208 |
| 122 | ABL1 | 0.47699805 |
| 123 | KSR2 | 0.46779223 |
| 124 | SGK1 | 0.45497446 |
| 125 | FLT3 | 0.43260640 |
| 126 | KDR | 0.41856546 |
| 127 | TAOK1 | 0.39987877 |
| 128 | PRKD1 | 0.35566573 |
| 129 | NEK2 | 0.34124956 |
| 130 | EGFR | 0.33235431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.18137673 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.59541136 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47573342 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.23053872 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15899054 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05275098 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90478884 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.90385834 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86062494 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 1.74313864 |
| 11 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71354303 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64871628 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56892215 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55335669 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53317901 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50931835 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48217666 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48097841 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44854167 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41438790 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39321657 |
| 22 | Hepatitis B_Homo sapiens_hsa05161 | 1.35773965 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35689064 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34917572 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33340505 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.31955107 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31954087 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31361099 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30438325 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29572572 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26109455 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.21323498 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20770540 |
| 34 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.20571281 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.20043009 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19189040 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17591179 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.15978560 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12550766 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.09742842 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09028624 |
| 42 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09008655 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.08452355 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08113124 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07142230 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.05589082 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02498373 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.99770784 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99621887 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.98366643 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.98222976 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98115597 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97834578 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97367332 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.97171008 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.94879085 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 0.94521328 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93374323 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92744405 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92600293 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91786614 |
| 62 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.90638173 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.89568589 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89080746 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88519300 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87690056 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87319831 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.86510635 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85772087 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84541745 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79814516 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79680340 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79446715 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78146903 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.73523658 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73082620 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72646751 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.72175831 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71997027 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71633733 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66600095 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66246008 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.65657865 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65588448 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65303500 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64471665 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64060183 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63991668 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63318599 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.62683303 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61431540 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61030870 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59861766 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.59086731 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58129375 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58112740 |
| 97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58011245 |
| 98 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57532233 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57277840 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56882406 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56762885 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55548184 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55053845 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53421413 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52496910 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.50517481 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.48194161 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48085569 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44143000 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44057027 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43640131 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43155316 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42854958 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42420511 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.42368391 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42363508 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41984961 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40818235 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.40027021 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39839636 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39837784 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39530549 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39085868 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38750344 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38036793 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37627471 |

